It has been a good week, but it has also been quite a quick run. The recent weakness is not necessarily bad if we successfully back test the breakout. The $94-$95 level on the XBI was the upper end of the range and was resistance. We clearly busted above that level this week, but it […]
August 16th Biotech Update
On a broader market perspective nothing much has changed. We really have no real momentum in either direction but I still think we have a couple of weeks of vacations before people start getting back and volume returns and we get a clearer picture of the sector sentiment or how it is going to developed […]
March 31st Biotech Update
Yesterday was a disappointment in many ways. To see the sector underperform yet again was frustrating. As frustrating as it was it does not take the move to $78 off the table and it’s good that we are rebounding today. I still think that a move to the $78 area is most likely in the […]
January 20th Biotech Update
We had our chance but the trend has remained our friend and we remain stuck in the range. It was not unexpected but still a little disappointing as it would have been nice to get that breakout. I do not think it makes a breakdown more likely but the grind in the range continues and […]
January 12th Biotech Update
The sector is setting up in an interesting manner. JPM weeks that have a red Monday tend to have a red week but we have been strong since then. Of course, there is a broader market strength that is probably helping the sector to a significant extend because the news has not been bad just […]
October 17th Biotech Update
Another week and another set of worries but the macro environment is about the same. We have the Fed and interest rates (and tied into that are the inflation numbers and potential recession caused by the rising rates). We also have the international political risks and this includes the war in Ukraine and do not […]
August 3rd Biotech Update
We started the week at the bottom of the range and within three days we are at the top of the range. I find days like this a little tough to judge. Big positive moves like this make it feel like there is very strong momentum but when they smack against the top of a […]
May 24th Biotech Update
It was a good start to the week but the yo-yo continues. I think if the broader market was not weak that the sector would be forming an uptrend. For the first time in a long time it feels like the sector wants to outperform the broader market. Our issue is that the broader market […]
May 9th Biotech Update
The sector continues to be a complete mess along with the broader market. We are at multi-year lows and this move lower has been relentless. I am sounding like a broken record but this has to see a dead cat bounce at some point. Of course, the one thing the sector has not done is […]
January 26th Biotech (and Ukraine) Update
We did not end completely green the other day but we had two really impressive drops and reversals in a row. It will be awhile before the market can top Monday and even though Tuesday still ended red it was a signal that the bottom may be in at least in the short term. Those […]
January 10th Biotech Update
Well, if you thought JPM 2021 was a disappointment you had not seen JPM 2022. While there can still be individual stock news I think the lack of any significant deals means that M&A is not going to be a theme in this conference. I guess the one advantage we have this year is that […]
November 17th Biotech Update
The sector is doing what it does. It is remaining in the range and aggravating investors with it continued under performance. This should be a seasonally strong period but we remain stuck in the range. Perhaps investors still have some lingering concerns about drug pricing reforms and the details that are being worked out. Or […]
November 3nd Biotech Update
The sector seems to be building some momentum (dare I say) but I guess it shows how low expectations were that two strong days in a row seems like such an accomplishment. We did get a drug price proposal in the bills in congress but it is a win for the sector. It allows […]
November 1st Biotech Update
A good start to the week but it is early in many ways. We would want to see this momentum build throughout the day and more importantly build across the days. The sector has had the occasional positive day but it has been a real struggle to string positive days together. Hopefully this is […]
August 23rd Biotech Update
What is happening? Do we actually have M&A that could be more broadly meaningful for the sector? I think we might actually have had one. Obviously we need to see how the sector ultimately reacts to the deal but it is setup as being really good for the sector and not just for one day […]
August 5th Biotech Update
Things got a little better for the sector with some green but we really need to get some momentum and accelerate to the upside. It is too easy for the bears to sell any rally and short without any real fear that the sector might move against a short position (or move against it more […]
August 4th Biotech Update
I have to say yesterday was pretty disappointing. We finally get some M&A and while it is not massive it is in a hot therapeutic modality and the sector trades lower. One would have thought that would have been enough to at least get a little rally if not something more meaningful. Perhaps it is […]
July 26th Biotech Update
It should be a busy week with some earnings and the Fed meeting. Of course there is nothing to start the week so we are back to the negative bias in the sector, which is not surprising. I still think the path of least resistance at this point is lower but with the potential of […]
June 21st Biotech (and MLP) Update
We has some M&A to start the week but not in the sector. Deals have been happening to a certain extent but they have been partnerships and not M&A. Is that the wave of the future? Buying private companies and partnerships when it is public. That has been the pattern so far this year and […]
May 26th Biotech Update
I almost feel like we are stuck in a no news period until earnings but then I remember that we still have ASCO coming up (even though I am not sure it will provide very many fireworks for the sector). I have been talking about the sector being potentially in a trading zone but it […]
